Stay informed with the latest litigation news. Explore now

IP Verse

Actelion Pharmaceuticals Us, Inc. V. Lannett Company, Inc. - 1:24-cv-01162

Explore the details of the Actelion Pharmaceuticals Us, Inc. V. Lannett Company, Inc. case under case number 1:24-cv-01162 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-01162
Filing Date
Oct 17, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Actelion Pharmaceuticals US, Inc. -
Lannett Company, Inc. -
Shinyaku Co., Ltd. -

Patents Involved

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US9284280B2
-US8791122B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 17, 2024Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shinyaku Co., Ltd.. (scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/08/2024. Date of Expiration of Patent: 06/25/2030.Thirty Month Stay Deadline: 3/9/2027. (scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Lannett Company, Inc. ( Filing fee $ 405, receipt number ADEDC-4526668.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(scs) (Entered: 10/18/2024)PACER Document
Oct 17, 2024No Summons Issued. (scs)PACER Document